$1.350
+0.010 (+0.75%)Zum Schluss
CABR-News
CABR-Events
Caring Brands and SanPellegrino Sign New Licensing Agreement
Caring Brands and SanPellegrino Cosmetics announced the execution of a revised multi-territory licensing agreement covering Photocil and Hair Enzyme Booster. The five-year agreement extends the company's commercial reach into Latin America, Russia, Australia, and New Zealand. "This expanded agreement reflects our confidence in SCPL's commercial execution and our shared vision for bringing these clinically validated technologies to patients across high-growth international markets in order to improve our revenue stream," said Glynn Wilson, CEO of Caring Brands.
Caring Brands Files to Sell 18.95M Shares of Common Stock
Caring Brands files to sell 18.95M shares of common stock for holders
Caring Brands Secures Two New US Patents
Caring Brands announced the issuance of two new United States patents covering proprietary methods and compositions designed to enhance enzymatic activity in hair follicles, further strengthening the Company's intellectual property portfolio supporting its Hair Enzyme Booster product. The newly issued patents, granted by the United States Patent and Trademark Office in January 2026, relate to technologies that increase sulfotransferase enzyme activity to improve the efficacy of topical hair loss treatments.
Caring Brands Enters Exclusive License Agreement with Itonis
Caring Brands entered into an exclusive worldwide license agreement with Itonis Inc. to manufacture, market, and distribute Emesyl, Itonis's over-the-counter nausea relief product. The agreement provides Caring Brands with full rights to commercialize Emesyl and to oversee all manufacturing activities associated with the product. Under the terms of the agreement, Caring Brands will assume responsibility for product manufacturing, marketing, sales strategy, and global distribution. Itonis will provide technical information, product formulation data, historical sales information, and intellectual property details to support Caring Brands' commercial launch and ongoing development efforts. The agreement includes a royalty structure based on future net sales, along with the potential for Caring Brands to earn equity in Itonis tied to revenue milestones. Caring Brands expects to provide further updates on product timelines, manufacturing progress, and commercial rollout as these initiatives advance.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.